Trial Profile
Reversal of neuromuscular block by sugammadex for peripheral nerve block using combined ultrasound and neurostimulation guidance under general anesthesia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Nov 2019
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 27 Nov 2019 Status changed from recruiting to completed, as reported by University Hospital Medical Information Network - Japan record.
- 03 Jul 2017 New trial record